(Q46558204)

23 December 2017

title

The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe (English)

1 reference

23 December 2017

1 reference

1 reference

1 reference

1 reference

D M Burger

1

1 reference

23 December 2017

A Huisman

2

1 reference

23 December 2017

N Van Ewijk

3

1 reference

23 December 2017

H Neisingh

4

1 reference

23 December 2017

P Van Uden

5

1 reference

23 December 2017

G A Rongen

6

1 reference

23 December 2017

P Koopmans

7

1 reference

23 December 2017

R J Bertz

8

1 reference

23 December 2017

language of work or name

English

0 references

publication date

4 June 2008

1 reference

23 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

23 December 2017

volume

84

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

698-703

1 reference

23 December 2017

Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

UDP-glucuronosyltransferases and clinical drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

7 January 2021

Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

7 January 2021

Oral Contraceptives Induce Lamotrigine Metabolism: Evidence from a Double-blind, Placebo-controlled Trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

7 January 2021

In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

7 January 2021

Brief report: enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy women

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.106

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.106

1 reference

23 December 2017

Dimensions Publication ID

1031887698

0 references

1 reference

23 December 2017